In addition to H19 which is known to be relevant toatherosclerosis (24), to the best of our knowledge, thereare no previous reports about H19 lncRNA expressionprofiling in PBMC in human CAD patients to compare ourresults to and provide comparative conclusions directly.Recently Zhang et al. (13) from China measured thecirculating levels of H19 lncRNA in plasma samples from300 patients with CAD using qRT-PCR. This evidence concerns the gene H19 and coronary artery disorder.